July 28, 202200:02:46

At-home ketamine therapy 'incredibly effective,' study finds; FDA approves Neuronetics' transcranial magnetic stimulation treatment for depression-related anxiety

Randi Haseman gives updates on the Behavioral Health industry.

No transcript available.